OLUMIANT® (baricitinib) 2-mg Tablets gets FDA approval to treat adult patients with moderately to severely active Rheumatoid Arthritis
Eli Lilly and Company and Incyte Corporation announced today that the U.S. Food and Drug Administration (FDA) has approved the 2-mg dose of OLUMIANT®...
Lupin’s Nagpur facility US FDA inspection concluded with no observations
Pharma major Lupin announced the successful completion of an inspection carried out by the US FDA at its Nagpur facility. The inspection concluded without...
U.S. FDA Approves Expanded Indication for Truvada for Reducing the Risk of Acquiring HIV-1 in Adolescents
Gilead Sciences, Inc. announced that the U.S. FDA has approved once-daily oral Truvada® (emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg)—in combination with safer sex...
Tasigna drug to treat children with rare form of leukemia receives FDA approval: Novartis
Novartis announced that the US FDA expanded the indication for Tasigna (nilotinib) to include treatment of first- and second-line pediatric patients one year of...
Personalised medicines, intelligent packaging and FDA deadlines seen as major trends for pharma packaging in 2018
Pharmapack Europe (#pharmapackeu) – organised by UBM – closed its most exciting edition to date, taking place at Paris Expo, Porte De Versailles on...
FDA Approves Avycaz for the Treatment of Patients with Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia
Allergan plc , a leading global pharmaceutical company, announced that the U.S. FDA has approved Allergan's supplemental New Drug Application (sNDA) to expand the...
GSK’S B vaccine prevents harmful disease among children; U.S FDA applauds
GlaxoSmithKline plc announced that it has received Breakthrough Therapy Designation from the U.S. FDA for its meningitis B vaccine Bexsero for the development...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...